Even though weight-loss surgeries cause greater weight loss and are known to reduce cancer risk, roughly as many cases of cancer developed among people taking GLP-1 drugs, results show
For individuals with metabolic conditions that make weight loss extremely difficult
The detailed composition of these diets appears in a recent publication 46
The adverse effects associated with tirzepatide use in patients at increased risk of cardiovascular events: a systematic review with meta-analysis and Trial Sequential Analysis
Kanwal F, Shubrook JH, Adams LA, et al
The Satiety and Clinical Adiposity Liraglutide Evidence (SCALE) Obesity and Prediabetes randomized, double-blind, placebo-controlled trial of 3.0 mg of once daily liraglutide achieved a mean 8.4 kg weight loss in patients with obesity without T2DM [7]